Press Releases
Kforce Reports Fourth Quarter and Full Year 2012 Results
-
Fourth Quarter Revenues of
$269.8 Million -
Fourth Quarter Net Income of
$8.6 Million , or$0.24 Per Share, Excluding Non-Cash Impairment Charge
-
Flex revenue per billing day of
$4.2 million in Q4 '12 increased 2.0% from$4.1 million in Q3 '12 and increased 2.2% from$4.1 million in Q4 '11. - Sequential percentage changes in Flex revenue on a billing day basis by segment were: 8.7% increase for HIM, 8.3% increase for Government Solutions, 2.1% increase for FA, and a 0.3% increase for Tech.
- Year-over-year changes in Flex revenue on a billing day basis were a 3.3% increase in HIM, 2.7% increase in Tech, 2.1% increase in Government Solutions, and a 0.2% increase in FA.
-
Search revenue of
$11.1 million in Q4 '12 decreased 10.3% from$12.4 million in Q3 '12 and increased 9.2% from$10.2 million in Q4 '11.
Financial highlights for the fourth quarter and 2012 include:
- Flex gross profit increased 30 basis points to 29.9% in Q4 '12 from 29.6% in Q3 '12 and increased 100 basis points from 28.9% in Q4 '11.
- Selling, general and administrative expenses as a percentage of revenues for Q4 '12 was 26.9% compared to 27.3% for Q4 '11.
-
At the end of Q4 '12, the Firm had bank debt of
$21.0 million , which was a result of the special dividend issued inDecember 2012 of$35.2 million and$19.0 million of open market repurchases ofKforce common stock during Q4 '12. There was no bank debt at the end of Q3 '12. -
Net income from continuing operations in Q4 '12 before the impact of the impairment charge was
$8.4 million , or$0.24 per share, an increase of 64.6% and 71.4%, respectively, from Q4 '11 which had net income of$5.1 million , or$0.14 per share.
On
The dial-in number is (877) 344-3890. The conference passcode is Kforce. The replay of the call will be available from
This call is being webcast by
About
The
Certain of the above statements contained in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements are within the meaning of that term in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Factors that could cause actual results to differ materially include the following: business conditions and growth in the staffing industry and general economy; competitive factors, risks due to shifts in the market demand, including, without limitation, shifts in demand for our Technology, Finance and Accounting, Health Information Management and Government Solutions segments, as well as the market for search and flexible staffing assignments; changes in the service mix; ability of the Firm to complete acquisitions; and the risk factors listed from
time to time in the Firm's reports filed with the
|
|||
Summary of Operations | |||
(In Thousands, Except Per Share Amounts) | |||
(Unaudited) | |||
Three Months Ended | |||
Dec. 31, 2012 |
Sept. 30, 2012 |
Dec. 31, 2011 |
|
Revenue by function: | |||
Technology | $ 167,616 | $ 170,577 | $ 160,822 |
Finance & accounting | 58,624 | 58,729 | 56,672 |
Health information management | 19,406 | 18,157 | 18,578 |
Government solutions | 24,193 | 22,698 | 23,269 |
Total revenue | 269,839 | 270,161 | 259,341 |
Costs of services | 181,259 | 181,399 | 177,091 |
Gross profit | 88,580 | 88,762 | 82,250 |
GP % | 32.8% | 32.9% | 31.7% |
Flex GP % | 29.9% | 29.6% | 28.9% |
Selling, general & administrative expenses | 72,540 | 70,367 | 70,849 |
Goodwill impairment | 3,858 | -- | -- |
Depreciation & amortization | 2,371 | 2,659 | 3,013 |
Income from operations | 9,811 | 15,736 | 8,388 |
Other expense, net | 171 | 288 | 349 |
Income from continuing operations, before income taxes | 9,640 | 15,448 | 8,039 |
Income tax expense | 3,718 | 6,173 | 2,952 |
Income from continuing operations | 5,922 | 9,275 | 5,087 |
Income (loss) from discontinued operations, net of income taxes | 198 | (7) | 1,998 |
Net income | $ 6,120 | $ 9,268 | $ 7,085 |
Earnings per share - diluted | $ 0.17 | $ 0.26 | $ 0.20 |
Adjusted EBITDA per share | $ 0.45 | $ 0.51 | $ 0.41 |
Shares outstanding - diluted | 35,573 | 36,243 | 35,709 |
Adjusted EBITDA | $ 16,070 | $ 18,415 | $ 14,584 |
Other information: | |||
Capital expenditures | $ 1,472 | $ 1,568 | $ 2,445 |
Equity-based compensation expense, net of income taxes | $ 33 | $ 23 | $ 2,037 |
Billing days | 62 | 63 | 61 |
|
||
Summary of Operations | ||
(In Thousands, Except Per Share Amounts) | ||
(Unaudited) | ||
Twelve Months Ended | ||
Dec. 31, 2012 |
Dec. 31, 2011 |
|
Revenue by function: | ||
Technology | $ 675,587 | $ 624,012 |
Finance & accounting | 238,476 | 219,575 |
Health information management | 76,992 | 68,711 |
Government solutions | 91,424 | 92,449 |
Total revenue | 1,082,479 | 1,004,747 |
Costs of services | 734,546 | 687,000 |
Gross profit | 347,933 | 317,747 |
GP % | 32.1% | 31.6% |
Flex GP % | 29.0% | 28.5% |
Selling, general & administrative expenses | 322,436 | 274,072 |
Goodwill impairment | 69,158 | -- |
Depreciation & amortization | 10,789 | 12,505 |
(Loss) income from operations | (54,450) | 31,170 |
Other expense, net | 1,116 | 1,256 |
(Loss) income from continuing operations, before income taxes | (55,566) | 29,914 |
Income tax (benefit) expense | (19,854) | 10,858 |
(Loss) income from continuing operations | (35,712) | 19,056 |
Income from discontinued operations, net of income taxes | 22,009 | 8,100 |
Net (loss) income | $ (13,703) | $ 27,156 |
Earnings (loss) per share - diluted | $ (0.38) | $ 0.70 |
Adjusted EBITDA per share | $ 1.42 | $ 1.43 |
Shares outstanding - diluted | 35,791 | 38,831 |
Adjusted EBITDA | $ 51,063 | $ 55,510 |
Other information: | ||
Capital expenditures | $ 6,518 | $ 7,662 |
Equity-based compensation expense, net of income taxes | $ 16,587 | $ 7,529 |
Billing days | 253 | 252 |
|
|||
Key Statistics | |||
(Unaudited) | |||
Q4 2012 | Q3 2012 | Q4 2011 | |
Total Firm | |||
Flex revenue (000's) | $ 258,743 | $ 257,790 | $ 249,183 |
Revenue per billing day (000's) | $ 4,173 | $ 4,092 | $ 4,085 |
Sequential flex revenue change | 0.4% | -1.2% | -0.1% |
Hours (000's) | 4,405 | 4,328 | 4,225 |
Flex GP % | 29.9% | 29.6% | 28.9% |
Search revenue (000's) | $ 11,096 | $ 12,371 | $ 10,158 |
Placements | 791 | 856 | 759 |
Average fee | $ 14,027 | $ 14,456 | $ 13,389 |
Billing days | 62 | 63 | 61 |
Technology | |||
Flex revenue (000's) | $ 163,282 | $ 165,342 | $ 156,543 |
Revenue per billing day (000's) | $ 2,634 | $ 2,625 | $ 2,566 |
Sequential flex revenue change | -1.2% | -0.4% | -2.3% |
Hours (000's) | 2,511 | 2,520 | 2,420 |
Flex GP % | 28.4% | 28.4% | 27.8% |
Search revenue (000's) | $ 4,334 | $ 5,235 | $ 4,279 |
Placements | 290 | 337 | 280 |
Average fee | $ 14,960 | $ 15,536 | $ 15,318 |
Finance & Accounting | |||
Flex revenue (000's) | $ 51,936 | $ 51,661 | $ 50,926 |
Revenue per billing day (000's) | $ 837 | $ 820 | $ 835 |
Sequential flex revenue change | 0.5% | -3.5% | 6.0% |
Hours (000's) | 1,607 | 1,545 | 1,517 |
Flex GP % | 30.8% | 30.9% | 30.0% |
Search revenue (000's) | $ 6,688 | $ 7,068 | $ 5,746 |
Placements | 498 | 513 | 450 |
Average fee | $ 13,434 | $ 13,783 | $ 12,759 |
Health Information Management | |||
Flex revenue (000's) | $ 19,332 | $ 18,089 | $ 18,445 |
Revenue per billing day (000's) | $ 312 | $ 287 | $ 302 |
Sequential flex revenue change | 6.9% | -8.5% | 7.2% |
Hours (000's) | 287 | 263 | 288 |
Flex GP % | 35.2% | 35.9% | 34.6% |
Search revenue (000's) | $ 74 | $ 68 | $ 133 |
Placements | 3 | 6 | 29 |
Average fee | $ 21,043 | $ 11,384 | $ 4,582 |
Government Solutions | |||
Flex revenue (000's) | $ 24,193 | $ 22,698 | $ 23,269 |
Revenue per billing day (000's) | $ 390 | $ 360 | $ 382 |
Sequential flex revenue change | 6.6% | 5.4% | -2.6% |
Flex GP % | 34.3% | 30.5% | 29.5% |
Kforce Inc. | ||
Consolidated Balance Sheets | ||
(In Thousands) | ||
(Unaudited) | ||
Dec. 31, 2012 | Dec. 31, 2011 | |
ASSETS | ||
Current Assets: | ||
Cash and cash equivalents | $ 1,381 | $ 939 |
Trade receivables, net of allowances | 151,570 | 174,764 |
Income tax refund receivable | 1,750 | 250 |
Deferred tax asset, net | 9,494 | 4,694 |
Prepaid expenses and other current assets | 7,364 | 5,592 |
Total current assets | 171,559 | 186,239 |
Fixed assets, net | 34,883 | 36,124 |
Other assets, net | 28,038 | 32,554 |
Deferred tax asset, net | 21,523 | 10,042 |
Intangible assets, net | 5,736 | 6,635 |
Goodwill | 63,410 | 138,078 |
Total assets | $ 325,149 | $ 409,672 |
LIABILITIES AND STOCKHOLDERS' EQUITY | ||
Current Liabilities: | ||
Accounts payable and other accrued liabilities | $ 36,205 | $ 26,314 |
Accrued payroll costs | 50,063 | 55,151 |
Other current liabilities | 11,564 | 1,463 |
Income taxes payable | 1,042 | 236 |
Total current liabilities | 98,874 | 83,164 |
Long-term debt - credit facility | 21,000 | 49,526 |
Long-term debt - other | 1,144 | 1,609 |
Other long-term liabilities | 34,285 | 42,258 |
Total liabilities | 155,303 | 176,557 |
Commitments and contingencies | ||
Stockholders' Equity: | ||
Preferred stock | -- | -- |
Common stock | 685 | 686 |
Additional paid-in capital | 400,688 | 372,212 |
Accumulated other comprehensive loss | (2,713) | (4,050) |
Retained earnings | 40,203 | 89,135 |
Treasury stock, at cost | (269,017) | (224,868) |
Total stockholders' equity | 169,846 | 233,115 |
Total liabilities and stockholders' equity | $ 325,149 | $ 409,672 |
|
||||||
Selected Financial Information and Reconciliations | ||||||
(In Thousands, Except Per Share Amounts) | ||||||
(Unaudited) | ||||||
Adjusted Net Income and Earnings Per Share Before Impairment Charge | ||||||
Three Months Ended |
Twelve Months Ended |
|||||
$ | Per share | $ | Per share | |||
Net income (loss) | $ 6,120 | $ 0.17 | $ (13,703) | $ (0.38) | ||
Goodwill impairment, pre-tax | 3,858 | 0.11 | 69,158 | 1.93 | ||
Tax benefit from impairment charge | (1,405) | (0.04) | (24,670) | (0.69) | ||
Goodwill impairment, after-tax | 2,453 | 0.07 | 44,488 | 1.24 | ||
Earnings Per Share Adjustment (*) | -- | -- | -- | (0.01) | ||
Adjusted net income and earnings per share before impairment charge | $ 8,573 | $ 0.24 | $ 30,785 | $ 0.85 | ||
Weighted average shares outstanding - basic | 35,530 | 35,791 | ||||
Weighted average shares outstanding - diluted | 35,573 | 36,025 | ||||
"Adjusted Net Income and Earnings Per Share Before Impairment Charge," a non-GAAP financial measure, is defined as net income before the non-cash impairment charges related to goodwill. "Adjusted Net Income and Earnings Per Share Before Impairment Charge" should not be considered a measure of financial performance under generally accepted accounting principles and has been provided for consistency and comparability of the 2012 results with net income and earnings per share from prior periods. | ||||||
(*) This earnings per share adjustment is necessary to properly reconcile net loss per share on a GAAP basis to Adjusted Net Income per share. Earnings Per Share Before Impairment Charge, a non-GAAP financial measure, is based on Net Income Before Impairment Charge and diluted weighted average shares outstanding; however, the reconciling items within the table above are based on basic weighted average shares outstanding, as the inclusion of dilutive securities such as stock options and stock awards would have an anti-dilutive effect on loss per share. | ||||||
Quarterly Adjusted EBITDA | ||||||
Three Months Ended | ||||||
Dec. 31, 2012 |
Sept. 30, 2012 |
Dec. 31, 2011 |
||||
$ | Per share | $ | Per share | $ | Per share | |
Net income | $ 6,120 | $ 0.17 | $ 9,268 | $ 0.26 | $ 7,085 | $ 0.20 |
Income (loss) from discontinued operations, net of income taxes | 198 | 0.00 | (7) | (0.00) | 1,998 | 0.06 |
Income from continuing operations | $ 5,922 | $ 0.17 | $ 9,275 | $ 0.26 | $ 5,087 | $ 0.14 |
Goodwill impairment, pre-tax | 3,858 | 0.11 | -- | -- | -- | -- |
Depreciation & amortization | 2,371 | 0.07 | 2,659 | 0.07 | 3,013 | 0.09 |
Amortization of restricted stock & PARS | 53 | 0.00 | 38 | 0.00 | 3,190 | 0.09 |
Interest expense and other | 148 | 0.00 | 270 | 0.01 | 342 | 0.01 |
Income tax expense | 3,718 | 0.10 | 6,173 | 0.17 | 2,952 | 0.08 |
Adjusted EBITDA | $ 16,070 | $ 0.45 | $ 18,415 | $ 0.51 | $ 14,584 | $ 0.41 |
Weighted average shares outstanding - basic | 35,530 | 36,204 | 34,549 | |||
Weighted average shares outstanding - diluted | 35,573 | 36,243 | 35,709 | |||
Full Year Adjusted EBITDA | ||||
Twelve Months Ended | ||||
Dec. 31, 2012 |
Dec. 31, 2011 |
|||
$ | Per share | $ | Per share | |
Net (loss) income | $ (13,703) | $ (0.38) | $ 27,156 | $ 0.70 |
Income from discontinued operations, net of income taxes | 22,009 | 0.62 | 8,100 | 0.21 |
(Loss) income from continuing operations | $ (35,712) | $ (1.00) | $ 19,056 | $ 0.49 |
Goodwill impairment, pre-tax | 69,158 | 1.93 | -- | -- |
Depreciation & amortization | 10,789 | 0.30 | 12,505 | 0.32 |
Acceleration of restricted stock & PARS | 22,158 | 0.62 | -- | -- |
Amortization of restricted stock & PARS | 3,530 | 0.10 | 11,819 | 0.30 |
Interest expense and other | 994 | 0.03 | 1,272 | 0.04 |
Income tax (benefit) expense | (19,854) | (0.55) | 10,858 | 0.28 |
Earnings Per Share Adjustment (*) | -- | (0.01) | -- | -- |
Adjusted EBITDA | $ 51,063 | $ 1.42 | $ 55,510 | $ 1.43 |
Weighted average shares outstanding - basic | 35,791 | 37,835 | ||
Weighted average shares outstanding - diluted | 36,025 | 38,831 | ||
Adjusted EBITDA, a non-GAAP financial measure, is defined as earnings before discontinued operations, non-cash impairment charges, interest, income taxes, depreciation and amortization and stock-based compensation expense. Adjusted EBITDA should not be considered a measure of financial performance under generally accepted accounting principles. Items excluded from Adjusted EBITDA are significant components in understanding and assessing financial performance. | ||||
(*) This earnings per share adjustment is necessary to properly reconcile net loss per share on a GAAP basis to Adjusted Net Income per share. Earnings Per Share Before Impairment Charge, a non-GAAP financial measure, is based on Net Income Before Impairment Charge and diluted weighted average shares outstanding; however, the reconciling items within the table above are based on basic weighted average shares outstanding, as the inclusion of dilutive securities such as stock options and stock awards would have an anti-dilutive effect on loss per share. | ||||
Adjusted Net Income and Earnings Per Share Before Impairment Charge and Adjusted EBITDA are key measures used by management to evaluate its operations and to provide useful information to investors. These measures should not be considered in isolation or as an alternative to net income, cash flows data or other financial statement information presented in the consolidated financial statements as indicators of financial performance or liquidity. These measurements are not determined in accordance with generally accepted accounting principles and are thus susceptible to varying calculations. The measures as presented may not be comparable to similarly titled measures of other companies. |
CONTACT:Source:Michael R. Blackman Chief Corporate Development Officer (813) 552-2927
News Provided by Acquire Media